(-0.19%) 5 202.75 points
(-0.14%) 39 139 points
(-0.27%) 18 138 points
(0.66%) $79.51
(-0.18%) $2.18
(-0.22%) $2 317.10
(0.76%) $27.81
(0.44%) $988.90
(0.19%) $0.932
(0.23%) $10.92
(0.19%) $0.802
(0.50%) $92.19
Live Chart Being Loaded With Signals
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs...
Stats | |
---|---|
Today's Volume | 109 414 |
Average Volume | 493 130 |
Market Cap | 109.23B |
EPS | INR0 ( 2024-02-01 ) |
Next earnings date | ( INR0 ) 2024-05-27 |
Last Dividend | INR5.00 ( 2023-08-10 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 289.35 |
ATR14 | INR1.075 (0.16%) |
Volume Correlation
Jubilant Pharmova Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jubilant Pharmova Limited Correlation - Currency/Commodity
Jubilant Pharmova Limited Financials
Annual | 2022 |
Revenue: | INR62.19B |
Gross Profit: | INR43.41B (69.80 %) |
EPS: | INR-3.83 |
FY | 2022 |
Revenue: | INR62.19B |
Gross Profit: | INR43.41B (69.80 %) |
EPS: | INR-3.83 |
FY | 2022 |
Revenue: | INR60.59B |
Gross Profit: | INR42.72B (70.51 %) |
EPS: | INR26.00 |
FY | 2021 |
Revenue: | INR59.64B |
Gross Profit: | INR42.10B (70.60 %) |
EPS: | INR52.48 |
Financial Reports:
No articles found.
Jubilant Pharmova Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR5.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR5.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.857 | 2003-09-18 |
Last Dividend | INR5.00 | 2023-08-10 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 22 | -- |
Total Paid Out | INR57.64 | -- |
Avg. Dividend % Per Year | 0.70% | -- |
Score | 1.6 | -- |
Div. Sustainability Score | 1.198 | |
Div.Growth Potential Score | 2.80 | |
Div. Directional Score | 1.999 | -- |
Year | Amount | Yield |
---|---|---|
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR3.00 | 0.37% |
2019 | INR4.50 | 0.63% |
2020 | INR5.00 | 0.94% |
2021 | INR5.00 | 0.78% |
2022 | INR5.00 | 0.85% |
2023 | INR5.00 | 1.38% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MATRIMONY.NS | Dividend Junior | 2023-08-03 | Annually | 7 | 0.41% | |
GRWRHITECH.NS | Dividend Junior | 2023-09-20 | Semi-Annually | 3 | 0.88% | |
BANDHANBNK.NS | Dividend Junior | 2023-08-11 | Sporadic | 7 | 0.20% | |
PPL.NS | Dividend Junior | 2023-09-18 | Annually | 6 | 0.62% | |
JWL.NS | Dividend Junior | 2023-09-12 | Insufficient data to determine frequency | 2 | 0.17% | |
DSSL.NS | Dividend Junior | 2023-08-23 | Annually | 6 | 0.34% | |
ACE.NS | Dividend Junior | 2023-08-17 | Annually | 18 | 0.23% | |
STARPAPER.NS | Dividend Junior | 2023-09-15 | Sporadic | 22 | 1.19% | |
MSUMI.NS | Dividend Junior | 2023-08-09 | Annually | 3 | 0.60% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00577 | 1.500 | 9.88 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.00701 | 1.500 | -1.033 | -1.550 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.512 | 1.000 | -0.551 | -0.551 | [3 - 30] |
operatingCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.673 | 1.000 | 2.11 | 2.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0588 | 1.000 | -0.825 | -0.825 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.198 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 292.27 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00701 | 2.50 | -0.664 | -1.550 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.720 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 35.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -42.15 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0862 | 1.000 | -0.345 | 0 | [0.1 - 0.5] |
Total Score | 2.80 |
Jubilant Pharmova Limited
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators